Zulong Sheng
Overview
Explore the profile of Zulong Sheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheng Z, Zhang R, Ji Z, Liu Z, Zhou Y
Front Cardiovasc Med
. 2025 Jan;
11:1501608.
PMID: 39872885
Background: Acute myocardial infarction (AMI), a subset of acute coronary syndrome, remains the major cause of mortality worldwide. Mitochondrial dysfunction is critically involved in AMI progression, and mitophagy plays a...
2.
Yan G, Sun R, Chen Z, Pan X, Sheng Z, Tang C
Drug Des Devel Ther
. 2021 May;
15:2025-2033.
PMID: 34012255
Purpose: Pulmonary hypertension (PH) is a pathological process mainly characterized by the progressive increase in pulmonary vascular resistance. The degradation of pulmonary artery smooth muscle cells (PASMCs) from contractile/differentiated phenotype...
3.
Chen Z, Pan X, Yan G, Sheng Z, Ma G
Clin Lab
. 2020 Jun;
66(6).
PMID: 32538053
Background: Acute myocardial infarction (AMI) is myocardial necrosis caused by acute and persistent ischemia and hypoxia of coronary arteries. AMI is one of the most common diseases in European countries...
4.
Lu W, Ma G, Sheng Z, Wang Q, Chen L, Qi J, et al.
Stem Cells Int
. 2020 May;
2020:2460158.
PMID: 32399040
Background: Ly6C monocytes are inflammatory cells that accumulate in an infarcted myocardium, and Ly6C monocytes are believed to be reparative and curb myocardial remodeling. NR4A1 is a novel target for...
5.
Zuo P, Zhu Y, Li Y, Zuo Z, Sheng Z, Yan G, et al.
Biochem Biophys Res Commun
. 2020 Mar;
526(1):253-260.
PMID: 32204916
Ischaemic heart disease is one of the leading causes of death. Protease-activated receptor 2 (PAR2) is widely expressed within the cardiovascular system and is known to mediate inflammatory processes in...
6.
Lu W, Sheng Z, Zhang Z, Ma G, Chen L, Huang J, et al.
J Cardiovasc Transl Res
. 2020 Jan;
13(2):171-180.
PMID: 31997261
Coronary collaterals can effectively improve myocardial blood supply to the area of CTO (chronic total coronary occlusion) and can, thus, reduce infarct size. LUNAR1(leukemia-induced noncoding activator RNA-1) is a specific...
7.
Chen Z, Pan X, Sheng Z, Yan G, Chen L, Ma G
Pathol Res Pract
. 2019 Jul;
215(9):152512.
PMID: 31296440
Coronary heart disease (CHD) is one of the main risks of death, which is mainly caused by coronary arteries arteriosclerosis. The present study aims to investigate the potential roles of...
8.
Chen Z, Pan X, Sheng Z, Yan G, Chen L, Ma G
Biol Pharm Bull
. 2019 Jun;
42(9):1517-1523.
PMID: 31204352
Atherosclerosis (AS) is a chronic inflammatory disease threatening human health, and vascular smooth muscle cells (VSMCs) are involved in AS processes. Baicalin is a flavonoid compound, which has anti-atherosclerotic effect....
9.
Sheng Z, Lu W, Zuo Z, Wang D, Zuo P, Yao Y, et al.
J Cell Biochem
. 2018 Dec;
120(6):9947-9955.
PMID: 30548297
Objective: MicroRNAs (miRNAs) have been shown to play crucial roles in the occurrence, development, and treatment of many cardiovascular diseases. Coronary heart disease (CAD)-related miRNAs are still a growing research...
10.
Ju C, Sheng Z, Wang Q, Li Y, Wang X, Li S, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2018 Dec;
51(1):41-50.
PMID: 30544204
Advanced glycation end products of BSA (AGE-BSA) contribute to the pathogenesis of diabetic vascular diseases. However, the roles and underlying mechanisms of AGE-BSA in diabetic vascular diseases remain largely unclear....